These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 38794646)

  • 1. Gender Differences in Liver Steatosis and Fibrosis in Overweight and Obese Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease before and after 8 Weeks of Very Low-Calorie Ketogenic Diet.
    Rinaldi R; De Nucci S; Donghia R; Donvito R; Cerabino N; Di Chito M; Penza A; Mongelli FP; Shahini E; Zappimbulso M; Pesole PL; Coletta S; Triggiani V; Cozzolongo R; Giannelli G; De Pergola G
    Nutrients; 2024 May; 16(10):. PubMed ID: 38794646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of an Eight Week Very Low-Calorie Ketogenic Diet (VLCKD) on White Blood Cell and Platelet Counts in Relation to Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Subjects with Overweight and Obesity.
    De Nucci S; Bonfiglio C; Donvito R; Di Chito M; Cerabino N; Rinaldi R; Sila A; Shahini E; Giannuzzi V; Pesole PL; Coletta S; Lanzilotta E; Piazzolla G; Cozzolongo R; Giannelli G; De Pergola G
    Nutrients; 2023 Oct; 15(20):. PubMed ID: 37892542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher-Level Steatosis Is Associated with a Greater Decrease in Metabolic Dysfunction-Associated Steatoic Liver Disease after Eight Weeks of a Very Low-Calorie Ketogenic Diet (VLCKD) in Subjects Affected by Overweight and Obesity.
    Sila A; De Nucci S; Bonfiglio C; Di Stasi V; Cerabino N; Di Chito M; Rinaldi R; Cantalice P; Shahini E; Giannuzzi V; Pesole PL; Coletta S; Tutino NM; Piazzolla G; Cozzolongo R; Giannelli G; De Pergola G
    Nutrients; 2024 Mar; 16(6):. PubMed ID: 38542785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effects of Eight Weeks' Very Low-Calorie Ketogenic Diet (VLCKD) on Liver Health in Subjects Affected by Overweight and Obesity.
    Rinaldi R; De Nucci S; Castellana F; Di Chito M; Giannuzzi V; Shahini E; Zupo R; Lampignano L; Piazzolla G; Triggiani V; Cozzolongo R; Giannelli G; De Pergola G
    Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of a Very Low Calorie Ketogenic Diet on Testicular Function in Overweight/Obese Men.
    Mongioì LM; Cimino L; Condorelli RA; Magagnini MC; Barbagallo F; Cannarella R; La Vignera S; Calogero AE
    Nutrients; 2020 Sep; 12(10):. PubMed ID: 32998364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of lifestyle changes including specific dietary intervention and physical activity in the management of patients with chronic hepatitis C--a randomized trial.
    Rusu E; Jinga M; Enache G; Rusu F; Dragomir AD; Ancuta I; Draguţ R; Parpala C; Nan R; Sima I; Ateia S; Stoica V; Cheţa DM; Radulian G
    Nutr J; 2013 Aug; 12():119. PubMed ID: 23941362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of Cardio-Metabolic Risk and Body Weight through a Multiphasic Very-Low Calorie Ketogenic Diet Program in Women with Overweight/Obesity: A Study in a Real-World Setting.
    Tragni E; Vigna L; Ruscica M; Macchi C; Casula M; Santelia A; Catapano AL; Magni P
    Nutrients; 2021 May; 13(6):. PubMed ID: 34073344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of very low calorie ketogenic diet (VLCKD) in patients with overweight and obesity: A systematic review and meta-analysis.
    Castellana M; Conte E; Cignarelli A; Perrini S; Giustina A; Giovanella L; Giorgino F; Trimboli P
    Rev Endocr Metab Disord; 2020 Mar; 21(1):5-16. PubMed ID: 31705259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of a 2-Month Very Low-Calorie Ketogenic Diet (VLCKD) Compared to a Standard Low-Calorie Diet in Reducing Visceral and Liver Fat Accumulation in Patients With Obesity.
    Cunha GM; Guzman G; Correa De Mello LL; Trein B; Spina L; Bussade I; Marques Prata J; Sajoux I; Countinho W
    Front Endocrinol (Lausanne); 2020; 11():607. PubMed ID: 33042004
    [No Abstract]   [Full Text] [Related]  

  • 10. A comprehensive approach to lifestyle intervention based on a calorie-restricted diet ameliorates liver fat in overweight/obese patients with NAFLD: a multicenter randomized controlled trial in China.
    Liu Z; Jin P; Liu Y; Zhang Z; Wu X; Weng M; Cao S; Wang Y; Zeng C; Yang R; Liu C; Sun P; Tian C; Li N; Zeng Q
    Nutr J; 2024 Jun; 23(1):64. PubMed ID: 38872173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simple proxies of insulin resistance identify obese metabolic dysfunction-associated fatty liver disease subjects with advanced liver disease.
    Petralli G; Salvati A; Tricò D; Ricco G; Colombatto P; Brunetto MR; Solini A
    Diabetes Metab Res Rev; 2024 Feb; 40(2):e3736. PubMed ID: 37839068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline HOMA IR and Circulating FGF21 Levels Predict NAFLD Improvement in Patients Undergoing a Low Carbohydrate Dietary Intervention for Weight Loss: A Prospective Observational Pilot Study.
    Watanabe M; Risi R; Camajani E; Contini S; Persichetti A; Tuccinardi D; Ernesti I; Mariani S; Lubrano C; Genco A; Spera G; Gnessi L; Basciani S
    Nutrients; 2020 Jul; 12(7):. PubMed ID: 32708435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance and central obesity determine hepatic steatosis and explain cardiovascular risk in steatotic liver disease.
    Semmler G; Balcar L; Wernly S; Völkerer A; Semmler L; Hauptmann L; Wernly B; Aigner E; Niederseer D; Datz C
    Front Endocrinol (Lausanne); 2023; 14():1244405. PubMed ID: 37842290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ketogenic diet corrects metabolic hypogonadism and preserves pancreatic ß-cell function in overweight/obese men: a single-arm uncontrolled study.
    La Vignera S; Cannarella R; Galvano F; Grillo A; Aversa A; Cimino L; Magagnini CM; Mongioì LM; Condorelli RA; Calogero AE
    Endocrine; 2021 May; 72(2):392-399. PubMed ID: 33063272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can the ketogenic diet improve our dreams? Effect of very low-calorie ketogenic diet (VLCKD) on sleep quality.
    Barrea L; Verde L; Di Lorenzo C; Savastano S; Colao A; Muscogiuri G
    J Transl Med; 2023 Jul; 21(1):479. PubMed ID: 37464397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Very Low-Carbohydrate Ketogenic Diet for the Treatment of Severe Obesity and Associated Non-Alcoholic Fatty Liver Disease: The Role of Sex Differences.
    D'Abbondanza M; Ministrini S; Pucci G; Nulli Migliola E; Martorelli EE; Gandolfo V; Siepi D; Lupattelli G; Vaudo G
    Nutrients; 2020 Sep; 12(9):. PubMed ID: 32916989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for non-alcoholic fatty liver disease among obese and overweight children: Prevalence and predictors.
    Thiagarajan S; Shrinuvasan S; Arun Babu T
    Indian J Gastroenterol; 2022 Feb; 41(1):63-68. PubMed ID: 35064452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Italian Ketogenic Mediterranean Diet in Overweight and Obese Patients with Prediabetes or Type 2 Diabetes.
    Ivan CR; Messina A; Cibelli G; Messina G; Polito R; Losavio F; Torre E; Monda V; Monda M; Quiete S; Casula E; Napoli N; Defeudis G
    Nutrients; 2022 Oct; 14(20):. PubMed ID: 36297044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Men and women respond differently to rapid weight loss: Metabolic outcomes of a multi-centre intervention study after a low-energy diet in 2500 overweight, individuals with pre-diabetes (PREVIEW).
    Christensen P; Meinert Larsen T; Westerterp-Plantenga M; Macdonald I; Martinez JA; Handjiev S; Poppitt S; Hansen S; Ritz C; Astrup A; Pastor-Sanz L; Sandø-Pedersen F; Pietiläinen KH; Sundvall J; Drummen M; Taylor MA; Navas-Carretero S; Handjieva-Darlenska T; Brodie S; Silvestre MP; Huttunen-Lenz M; Brand-Miller J; Fogelholm M; Raben A
    Diabetes Obes Metab; 2018 Dec; 20(12):2840-2851. PubMed ID: 30088336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.